Which has higher earnings & valuation, INMD or TMDX?

TransMedics Group has higher revenue and earnings than InMode. InMode is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InMode $370.49M 2.30 $93.83M $1.23 12.07 TransMedics Group $605.49M 5.05 $190.29M $3.89 22.73

Does the media prefer INMD or TMDX?

In the previous week, TransMedics Group had 6 more articles in the media than InMode. MarketBeat recorded 9 mentions for TransMedics Group and 3 mentions for InMode. TransMedics Group's average media sentiment score of 1.39 beat InMode's score of 0.62 indicating that TransMedics Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InMode 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TransMedics Group 5 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, INMD or AXGN?

InMode has higher revenue and earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InMode $370.49M 2.30 $93.83M $1.23 12.07 AxoGen $251.17M 11.02 -$15.70M -$0.68 N/A

Is INMD or AXGN more profitable?

InMode has a net margin of 20.69% compared to AxoGen's net margin of -13.36%. InMode's return on equity of 11.99% beat AxoGen's return on equity. Company Net Margins Return on Equity Return on Assets InMode 20.69% 11.99% 10.60% AxoGen -13.36% -8.90% -6.47%

Does the media favor INMD or AXGN?

In the previous week, AxoGen had 6 more articles in the media than InMode. MarketBeat recorded 9 mentions for AxoGen and 3 mentions for InMode. AxoGen's average media sentiment score of 1.35 beat InMode's score of 0.62 indicating that AxoGen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InMode 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AxoGen 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, BFLY or INMD?

InMode has higher revenue and earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Butterfly Network $97.61M 23.13 -$77.06M -$0.29 N/A InMode $370.49M 2.30 $93.83M $1.23 12.07

Is BFLY or INMD more profitable?

InMode has a net margin of 20.69% compared to Butterfly Network's net margin of -66.74%. InMode's return on equity of 11.99% beat Butterfly Network's return on equity. Company Net Margins Return on Equity Return on Assets Butterfly Network -66.74% -33.99% -22.96% InMode 20.69% 11.99% 10.60%

Does the media refer more to BFLY or INMD?

In the previous week, Butterfly Network had 1 more articles in the media than InMode. MarketBeat recorded 4 mentions for Butterfly Network and 3 mentions for InMode. Butterfly Network's average media sentiment score of 1.03 beat InMode's score of 0.62 indicating that Butterfly Network is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Butterfly Network 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InMode 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, ATRC or INMD?

InMode has lower revenue, but higher earnings than AtriCure. InMode is trading at a lower price-to-earnings ratio than AtriCure, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AtriCure $534.53M 4.62 -$11.45M $0.21 231.14 InMode $370.49M 2.30 $93.83M $1.23 12.07

Is ATRC or INMD more profitable?

InMode has a net margin of 20.69% compared to AtriCure's net margin of 1.85%. InMode's return on equity of 11.99% beat AtriCure's return on equity. Company Net Margins Return on Equity Return on Assets AtriCure 1.85% 2.34% 1.77% InMode 20.69% 11.99% 10.60%

Does the media favor ATRC or INMD?

In the previous week, AtriCure had 17 more articles in the media than InMode. MarketBeat recorded 20 mentions for AtriCure and 3 mentions for InMode. AtriCure's average media sentiment score of 0.90 beat InMode's score of 0.62 indicating that AtriCure is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AtriCure 11 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive InMode 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, ESTA or INMD?

InMode has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Establishment Labs $211.08M 9.97 -$51.06M -$1.31 N/A InMode $370.49M 2.30 $93.83M $1.23 12.07

Is ESTA or INMD more profitable?

InMode has a net margin of 20.69% compared to Establishment Labs' net margin of -15.82%. InMode's return on equity of 11.99% beat Establishment Labs' return on equity. Company Net Margins Return on Equity Return on Assets Establishment Labs -15.82% -196.69% -10.73% InMode 20.69% 11.99% 10.60%

Does the media refer more to ESTA or INMD?

In the previous week, Establishment Labs had 5 more articles in the media than InMode. MarketBeat recorded 8 mentions for Establishment Labs and 3 mentions for InMode. Establishment Labs' average media sentiment score of 1.48 beat InMode's score of 0.62 indicating that Establishment Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive InMode 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

InMode (INMD) Competitors

$14.85 +0.01 (+0.07%)

As of 08/28/2026 04:00 PM Eastern

Compare

INMD vs. TMDX, AXGN, BFLY, ATRC, and ESTA

Should you buy InMode stock or one of its competitors? InMode's main competitors and comparable companies include TransMedics Group (TMDX), AxoGen (AXGN), Butterfly Network (BFLY), AtriCure (ATRC), and Establishment Labs (ESTA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does InMode compare to TransMedics Group?

InMode (NASDAQ:INMD) and TransMedics Group (NASDAQ:TMDX) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, analyst recommendations, dividends, valuation and profitability.

InMode presently has a consensus price target of $16.00, indicating a potential upside of 7.74%. TransMedics Group has a consensus price target of $124.18, indicating a potential upside of 40.43%. Given TransMedics Group's stronger consensus rating and higher probable upside, analysts clearly believe TransMedics Group is more favorable than InMode.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
TransMedics Group	1 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

68.0% of InMode shares are held by institutional investors. Comparatively, 99.7% of TransMedics Group shares are held by institutional investors. 6.9% of InMode shares are held by insiders. Comparatively, 6.9% of TransMedics Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

TransMedics Group has a net margin of 22.69% compared to InMode's net margin of 20.69%. TransMedics Group's return on equity of 15.88% beat InMode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InMode	20.69%	11.99%	10.60%
TransMedics Group	22.69%	15.88%	5.95%

InMode has a beta of 1.89, suggesting that its share price is 89% more volatile than the broader market. Comparatively, TransMedics Group has a beta of 1.9, suggesting that its share price is 90% more volatile than the broader market.

In the previous week, TransMedics Group had 6 more articles in the media than InMode. MarketBeat recorded 9 mentions for TransMedics Group and 3 mentions for InMode. TransMedics Group's average media sentiment score of 1.39 beat InMode's score of 0.62 indicating that TransMedics Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InMode	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
TransMedics Group	5 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

TransMedics Group has higher revenue and earnings than InMode. InMode is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InMode	$370.49M	2.30	$93.83M	$1.23	12.07
TransMedics Group	$605.49M	5.05	$190.29M	$3.89	22.73

Summary

TransMedics Group beats InMode on 14 of the 16 factors compared between the two stocks.

How does InMode compare to AxoGen?

InMode (NASDAQ:INMD) and AxoGen (NASDAQ:AXGN) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, media sentiment, risk and dividends.

InMode has higher revenue and earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InMode	$370.49M	2.30	$93.83M	$1.23	12.07
AxoGen	$251.17M	11.02	-$15.70M	-$0.68	N/A

InMode has a beta of 1.89, indicating that its stock price is 89% more volatile than the broader market. Comparatively, AxoGen has a beta of 1.11, indicating that its stock price is 11% more volatile than the broader market.

InMode presently has a consensus target price of $16.00, indicating a potential upside of 7.74%. AxoGen has a consensus target price of $51.56, indicating a potential upside of 0.17%. Given InMode's higher probable upside, analysts plainly believe InMode is more favorable than AxoGen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
AxoGen	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.75

InMode has a net margin of 20.69% compared to AxoGen's net margin of -13.36%. InMode's return on equity of 11.99% beat AxoGen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InMode	20.69%	11.99%	10.60%
AxoGen	-13.36%	-8.90%	-6.47%

In the previous week, AxoGen had 6 more articles in the media than InMode. MarketBeat recorded 9 mentions for AxoGen and 3 mentions for InMode. AxoGen's average media sentiment score of 1.35 beat InMode's score of 0.62 indicating that AxoGen is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InMode	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AxoGen	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

68.0% of InMode shares are owned by institutional investors. Comparatively, 80.3% of AxoGen shares are owned by institutional investors. 6.9% of InMode shares are owned by company insiders. Comparatively, 2.4% of AxoGen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

InMode beats AxoGen on 10 of the 16 factors compared between the two stocks.

How does InMode compare to Butterfly Network?

Butterfly Network (NYSE:BFLY) and InMode (NASDAQ:INMD) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, dividends, analyst recommendations, earnings and profitability.

InMode has higher revenue and earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Butterfly Network	$97.61M	23.13	-$77.06M	-$0.29	N/A
InMode	$370.49M	2.30	$93.83M	$1.23	12.07

In the previous week, Butterfly Network had 1 more articles in the media than InMode. MarketBeat recorded 4 mentions for Butterfly Network and 3 mentions for InMode. Butterfly Network's average media sentiment score of 1.03 beat InMode's score of 0.62 indicating that Butterfly Network is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Butterfly Network	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InMode	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

InMode has a net margin of 20.69% compared to Butterfly Network's net margin of -66.74%. InMode's return on equity of 11.99% beat Butterfly Network's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Butterfly Network	-66.74%	-33.99%	-22.96%
InMode	20.69%	11.99%	10.60%

Butterfly Network currently has a consensus target price of $5.56, indicating a potential downside of 34.40%. InMode has a consensus target price of $16.00, indicating a potential upside of 7.74%. Given InMode's higher probable upside, analysts clearly believe InMode is more favorable than Butterfly Network.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Butterfly Network	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

37.9% of Butterfly Network shares are owned by institutional investors. Comparatively, 68.0% of InMode shares are owned by institutional investors. 22.0% of Butterfly Network shares are owned by insiders. Comparatively, 6.9% of InMode shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Butterfly Network has a beta of 2.09, meaning that its stock price is 109% more volatile than the broader market. Comparatively, InMode has a beta of 1.89, meaning that its stock price is 89% more volatile than the broader market.

Summary

InMode beats Butterfly Network on 9 of the 16 factors compared between the two stocks.

How does InMode compare to AtriCure?

AtriCure (NASDAQ:ATRC) and InMode (NASDAQ:INMD) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, earnings and risk.

AtriCure has a beta of 1.2, meaning that its stock price is 20% more volatile than the broader market. Comparatively, InMode has a beta of 1.89, meaning that its stock price is 89% more volatile than the broader market.

In the previous week, AtriCure had 17 more articles in the media than InMode. MarketBeat recorded 20 mentions for AtriCure and 3 mentions for InMode. AtriCure's average media sentiment score of 0.90 beat InMode's score of 0.62 indicating that AtriCure is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AtriCure	11 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
InMode	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

InMode has lower revenue, but higher earnings than AtriCure. InMode is trading at a lower price-to-earnings ratio than AtriCure, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AtriCure	$534.53M	4.62	-$11.45M	$0.21	231.14
InMode	$370.49M	2.30	$93.83M	$1.23	12.07

InMode has a net margin of 20.69% compared to AtriCure's net margin of 1.85%. InMode's return on equity of 11.99% beat AtriCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AtriCure	1.85%	2.34%	1.77%
InMode	20.69%	11.99%	10.60%

AtriCure currently has a consensus target price of $49.89, indicating a potential upside of 2.78%. InMode has a consensus target price of $16.00, indicating a potential upside of 7.74%. Given InMode's higher possible upside, analysts clearly believe InMode is more favorable than AtriCure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AtriCure	0 Sell rating(s)	4 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.75
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

99.1% of AtriCure shares are owned by institutional investors. Comparatively, 68.0% of InMode shares are owned by institutional investors. 4.0% of AtriCure shares are owned by company insiders. Comparatively, 6.9% of InMode shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

AtriCure beats InMode on 9 of the 17 factors compared between the two stocks.

How does InMode compare to Establishment Labs?

Establishment Labs (NASDAQ:ESTA) and InMode (NASDAQ:INMD) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

In the previous week, Establishment Labs had 5 more articles in the media than InMode. MarketBeat recorded 8 mentions for Establishment Labs and 3 mentions for InMode. Establishment Labs' average media sentiment score of 1.48 beat InMode's score of 0.62 indicating that Establishment Labs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
InMode	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Establishment Labs currently has a consensus price target of $100.25, suggesting a potential upside of 41.92%. InMode has a consensus price target of $16.00, suggesting a potential upside of 7.74%. Given Establishment Labs' stronger consensus rating and higher possible upside, equities research analysts clearly believe Establishment Labs is more favorable than InMode.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78
InMode	1 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

InMode has a net margin of 20.69% compared to Establishment Labs' net margin of -15.82%. InMode's return on equity of 11.99% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-15.82%	-196.69%	-10.73%
InMode	20.69%	11.99%	10.60%

72.9% of Establishment Labs shares are owned by institutional investors. Comparatively, 68.0% of InMode shares are owned by institutional investors. 10.0% of Establishment Labs shares are owned by company insiders. Comparatively, 6.9% of InMode shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

InMode has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	9.97	-$51.06M	-$1.31	N/A
InMode	$370.49M	2.30	$93.83M	$1.23	12.07

Establishment Labs has a beta of 1.07, meaning that its share price is 7% more volatile than the broader market. Comparatively, InMode has a beta of 1.89, meaning that its share price is 89% more volatile than the broader market.

Summary

Establishment Labs and InMode tied by winning 8 of the 16 factors compared between the two stocks.

Get InMode News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

INMD vs. The Competition

Export

Metric	InMode	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$853.02M	$5.78B	$7.23B	$12.94B
Dividend Yield	N/A	1.75%	2.54%	11.02%
P/E Ratio	12.07	25.92	273.45	25.45
Price / Sales	2.30	44.08	621.81	95.45
Price / Cash	9.95	32.99	79.29	54.21
Price / Book	1.36	6.18	12.97	6.14
Net Income	$93.83M	$149.01M	$3.48B	$348.86M
7 Day Performance	-1.39%	-0.24%	0.13%	-0.80%
1 Month Performance	-1.98%	7.85%	8.37%	5.56%
1 Year Performance	-0.60%	6.22%	24.55%	15.57%

InMode Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
INMD InMode	1.3854 of 5 stars	$14.85 +0.1%	$16.00 +7.7%	-0.5%	$853.02M	$370.49M	12.07	480
TMDX TransMedics Group	4.5103 of 5 stars	$93.60 -1.2%	$124.18 +32.7%	-24.2%	$3.28B	$605.49M	24.06	210	Positive News
AXGN AxoGen	2.0436 of 5 stars	$49.23 -2.3%	$51.00 +3.6%	+217.3%	$2.71B	$225.21M	N/A	450	Positive News Analyst Forecast
BFLY Butterfly Network	1.3991 of 5 stars	$8.95 -6.3%	$5.56 -37.8%	+418.7%	$2.54B	$97.61M	N/A	460	Positive News
ATRC AtriCure	2.6266 of 5 stars	$49.28 +0.6%	$48.63 -1.3%	+30.4%	$2.49B	$569.62M	234.68	1,300	Analyst Forecast Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:INMD) was last updated on 8/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

InMode (INMD) Competitors

INMD vs. TMDX, AXGN, BFLY, ATRC, and ESTA

How does InMode compare to TransMedics Group?

Summary

How does InMode compare to AxoGen?

Summary

How does InMode compare to Butterfly Network?

Summary

How does InMode compare to AtriCure?

Summary

How does InMode compare to Establishment Labs?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INMD vs. The Competition

InMode Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

InMode (INMD) Competitors

INMD vs. TMDX, AXGN, BFLY, ATRC, and ESTA

How does InMode compare to TransMedics Group?

Do analysts prefer INMD or TMDX?

Do insiders & institutionals believe in INMD or TMDX?

Is INMD or TMDX more profitable?

Which has more volatility & risk, INMD or TMDX?

Does the media prefer INMD or TMDX?

Which has higher earnings & valuation, INMD or TMDX?

Summary

How does InMode compare to AxoGen?

Which has better valuation & earnings, INMD or AXGN?

Which has more risk & volatility, INMD or AXGN?

Do analysts recommend INMD or AXGN?

Is INMD or AXGN more profitable?

Does the media favor INMD or AXGN?

Do institutionals and insiders believe in INMD or AXGN?

Summary

How does InMode compare to Butterfly Network?

Which has better earnings & valuation, BFLY or INMD?

Does the media refer more to BFLY or INMD?

Is BFLY or INMD more profitable?

Do analysts recommend BFLY or INMD?

Do insiders & institutionals have more ownership in BFLY or INMD?

Which has more risk and volatility, BFLY or INMD?

Summary

How does InMode compare to AtriCure?

Which has more risk & volatility, ATRC or INMD?

Does the media favor ATRC or INMD?

Which has stronger earnings and valuation, ATRC or INMD?

Is ATRC or INMD more profitable?

Do analysts rate ATRC or INMD?

Do insiders & institutionals believe in ATRC or INMD?

Summary

How does InMode compare to Establishment Labs?

Does the media refer more to ESTA or INMD?

Do analysts recommend ESTA or INMD?

Is ESTA or INMD more profitable?

Do insiders and institutionals hold more shares of ESTA or INMD?

Which has higher earnings and valuation, ESTA or INMD?

Which has more risk and volatility, ESTA or INMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INMD vs. The Competition

InMode Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools